Werewolf Therapeutics Inc... (HOWL)
NASDAQ: HOWL
· Real-Time Price · USD
1.33
0.01 (0.76%)
At close: Aug 15, 2025, 3:59 PM
1.35
1.50%
After-hours: Aug 15, 2025, 05:47 PM EDT
Werewolf Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M | -7.43M |
Depreciation & Amortization | 406K | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 434K | 425K | 417K | 404K | 185K | 98K | 48K | 67K | 62K | 39K |
Stock-Based Compensation | 1.79M | 2.01M | 1.91M | 2.01M | 2.6M | 2.31M | 1.87M | 2.1M | 1.93M | 2.11M | 1.94M | 1.94M | 1.78M | 1.75M | 1.3M | 1.48M | 781K | 539K |
Other Working Capital | n/a | n/a | -6K | 299K | -2.13M | -447K | 4.64M | -3M | -7.98M | -1.41M | -2.85M | -4.25M | 10.68M | -160K | 3.19M | 1.13M | -1.69M | -1.36M |
Other Non-Cash Items | 619K | -2.86M | 749K | -6K | -573K | 468K | 3.26M | 3.74M | 409K | -612K | 653K | 295K | 840K | 383K | 11K | 172K | 170K | 166K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.81M | -3.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -432K | 3.05M | 1.75M | 589K | -2.34M | 4.63M | -2.09M | -8.6M | 163K | -2.95M | -5.16M | 11.49M | -834K | 3.84M | -377K | -552K | -635K |
Operating Cash Flow | -15.16M | -18.95M | -14.25M | -12.46M | -14.18M | -15.3M | -4.58M | -7.21M | -10.92M | -9.9M | -11.87M | -14.47M | -303K | -13.95M | -12.67M | -12.42M | -10.46M | -7.33M |
Capital Expenditures | n/a | n/a | -123K | -3K | -17K | -111K | -198K | -221K | -182K | -168K | -518K | -1.95M | -1.11M | -28K | -272K | -102K | -111K | -13K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -123K | -3K | -17K | -111K | -198K | -221K | -182K | -168K | -518K | -1.95M | -1.11M | -28K | -272K | -102K | -111K | -13K |
Debt Repayment | n/a | n/a | 10M | n/a | -10M | n/a | n/a | n/a | n/a | 40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 388K | n/a | 13.64M | 23K | -597K | 12K | 191K | -141K | 50K | n/a | -174K | -32K | -238K | 159K | 38K | -276K | 110.2M | -538K |
Financial Cash Flow | 388K | n/a | 2.55M | -6K | -9.72M | 20.26M | 9.07M | 41K | 692K | 48.62M | 1.26M | 11.08M | 3.42M | 159K | 38K | -276K | 110.2M | -538K |
Net Cash Flow | -14.78M | -18.95M | -11.83M | -12.47M | -3.89M | 4.85M | 4.08M | -7.18M | -10.41M | 38.56M | -11.13M | -5.35M | 2M | -13.82M | -12.91M | -12.79M | 99.63M | -7.88M |
Free Cash Flow | -15.16M | -18.95M | -14.38M | -12.46M | -14.19M | -15.41M | -4.78M | -7.43M | -11.1M | -10.07M | -12.39M | -16.43M | -1.41M | -13.98M | -12.95M | -12.52M | -10.57M | -7.34M |